Repligen
RGEN
#1853
Rank
$11.09 B
Marketcap
$173.49
Share price
2.97%
Change (1 day)
19.66%
Change (1 year)
Categories

Repligen (RGEN) - P/B ratio

P/B ratio as of November 2026 : 5.23

According to Repligen 's latest financial reports the company has a price-to-book ratio of 14.0769.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Repligen - P/B ratio (from 2001 to 2026)

P/B ratio by year

Year P/B ratio Change
2026-12-31N/A-100%
2025-12-314.396.27%
2024-12-314.13-19.1%
2023-12-315.113.84%
2022-12-314.92-41.2%
2021-12-318.3722.02%
2020-12-316.8650.85%
2019-12-314.5520.81%
2018-12-313.7640.83%
2017-12-312.67-56.75%
2016-12-316.18-18.64%
2015-12-317.5930.75%
2014-12-315.8138.56%
2013-12-314.1980%
2012-12-312.3348.22%
2011-12-311.57-25.05%
2010-12-312.1011.94%
2009-12-311.8713.48%
2008-12-311.65-45.55%
2007-12-313.03-10.17%
2006-12-313.37-27.58%
2005-12-314.6632.78%
2004-12-313.51-18.64%
2003-12-314.3135.83%
2002-12-313.17

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Pfizer
PFE
1.95-62.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
4.88-6.77%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
18.8 260.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
5.47 4.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
-1.62-130.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-9.20-275.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
4.52-13.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
5.42 3.57%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1.71-67.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
5.56 6.33%๐Ÿ‡บ๐Ÿ‡ธ USA